Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
NK Cell Therapy Advances, Enabled by Precision Models
Natural Killer Cells on the Loose
Seeking New Users for iSeq
The Changing Sequencing Landscape
For full access to this article login to GEN Select now.
Raising the Bar of Cell Line Authentication
Researchers May Be Slow to Implement Protocols Unless They Are Pressured
- Imagine publishing a paper, accepting a research grant, or recruiting patients for a clinical trial only to discover that the esophageal cancer cell line used in your disease model actually came from a different tumor type. It’s a scientist’s nightmare, but it became an unfortunate reality for researchers working ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.